Smithfield Trust’s Pacific Biosciences PACB Stock Holding History

Smithfield Trust’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Hold	774	–	–	﹤0.01%	1068
2025 Q4	$1K	Hold	774	–	–	﹤0.01%	1074
2025 Q3	$1K	Hold	774	–	–	﹤0.01%	1013
2025 Q2	$1K	Hold	774	–	–	﹤0.01%	1030
2025 Q1	$1K	Hold	774	–	–	﹤0.01%	1034
2024 Q4	$1K	Hold	774	–	–	﹤0.01%	1042
2024 Q3	$1K	Hold	774	–	–	﹤0.01%	1010
2024 Q2	$1K	Hold	774	–	–	﹤0.01%	985
2024 Q1	$3K	Hold	774	–	–	﹤0.01%	984
2023 Q4	$8K	Buy	+774	New	+$6.33K	﹤0.01%	864
2022 Q3	–	Sell	-4,862	Closed	-$21K	–	1082
2022 Q2	$21K	Hold	4,862	–	–	﹤0.01%	659
2022 Q1	$44K	Hold	4,862	–	–	﹤0.01%	577
2021 Q4	$99K	Hold	4,862	–	–	0.01%	451
2021 Q3	$124K	Hold	4,862	–	–	0.01%	395
2021 Q2	$170K	Hold	4,862	–	–	0.01%	345
2021 Q1	$162K	Hold	4,862	–	–	0.01%	354
2020 Q4	$126K	Hold	4,862	–	–	0.01%	395
2020 Q3	$48K	Hold	4,862	–	–	﹤0.01%	509
2020 Q2	$17K	Hold	4,862	–	–	﹤0.01%	649
2020 Q1	$15K	Hold	4,862	–	–	﹤0.01%	623
2019 Q4	$25K	Hold	4,862	–	–	﹤0.01%	600
2019 Q3	$25K	Hold	4,862	–	–	﹤0.01%	623
2019 Q2	$29K	Hold	4,862	–	–	﹤0.01%	596
2019 Q1	$35K	Hold	4,862	–	–	﹤0.01%	531
2018 Q4	$36K	Hold	4,862	–	–	﹤0.01%	515
2018 Q3	$26K	Hold	4,862	–	–	﹤0.01%	613
2018 Q2	$17K	Hold	4,862	–	–	﹤0.01%	671
2018 Q1	$10K	Hold	4,862	–	–	﹤0.01%	729
2017 Q4	$13K	Hold	4,862	–	–	﹤0.01%	715
2017 Q3	$26K	Hold	4,862	–	–	﹤0.01%	621
2017 Q2	$17K	Hold	4,862	–	–	﹤0.01%	665
2017 Q1	$25K	Hold	4,862	–	–	﹤0.01%	620
2016 Q4	$18K	Hold	4,862	–	–	﹤0.01%	647
2016 Q3	$44K	Sell	4,862 -486	-9%	-$4.06K	0.01%	532
2016 Q2	$38K	Hold	5,348	–	–	0.01%	534
2016 Q1	$45K	Hold	5,348	–	–	0.01%	499
2015 Q4	$70K	Buy	+5,348	New	+$48K	0.01%	443

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smithfield Trust's PACB Position: Q1 2026 in Review

Smithfield Trust held its Pacific Biosciences (PACB) position steady in Q1 2026 at 774 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Smithfield Trust first reported a position in PACB in Q4 2015 and has held it in 37 quarters since. The position peaked at $170K in Q2 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

Smithfield Trust held 774 shares of Pacific Biosciences worth $1K as of Q1 2026.
Smithfield Trust left its Pacific Biosciences share count unchanged in Q1 2026.
Pacific Biosciences made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #1068 holding.
Smithfield Trust first reported a position in Pacific Biosciences in Q4 2015 and has held it in 37 quarters since.
Smithfield Trust's Pacific Biosciences position peaked at $170K in Q2 2021.
229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.